Patient engagement in oncology
Patient engagement in oncology
Patient engagement in oncology
Human medicines European public assessment report (EPAR): Oxervate, cenegermin, Date of authorisation: 06/07/2017, Revision: 3, Status: Authorised
Small and medium-sized enterprises info day, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 October 2024, 09:30 (CEST) to 18 October 2024, 16:15 (CEST)
Fostering regulatory collaboration to improve access to mpox medicines
Human medicines European public assessment report (EPAR): Tracleer, bosentan, Date of authorisation: 14/05/2002, Revision: 45, Status: Authorised
Highlights from the first Expert Panels and Notified Bodies workshop, Online, European Medicines Agency, Amsterdam, the Netherlands, 22 April 2024
Workshop with Notified Bodies on the Mandatory Scope of the CECP and PECP, Online, European Medicines Agency, Amsterdam, the Netherlands, 22 April 2024
Veterinary medicines European public assessment report (EPAR): BTVPUR, inactivated vaccine against bluetongue virus serotypes 1 and 8, Status: Authorised
Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 2026, European Medicines Agency, Amsterdam, the Netherlands, from 23 November 2026 to 26 November 2026
Veterinary medicines European public assessment report (EPAR): Nobilis Influenza H5N2, adjuvanted inactivated vaccine against avian influenza virus type A, subtype H5, Status: Authorised